Question Title

* 1. Please confim your Full Name, Email Address and Phone number.

Question Title

* 2. How did you hear about this study?

Question Title

* 3. Are you, or any member of your household, employed by the pharmaceutical industry on a full-time or consultancy basis, or is any member of your household employed by a communication or advertising industry related to pharmaceutical products?

Question Title

* 4. How old are you?

Question Title

* 5. What gender do you identify with?

Question Title

* 6. Have you ever received a diagnosis of immune thrombocytopenia from a healthcare professional? This condition may also be referred to as immune thrombocytopenia purpura, ITP, or low platelet counts in the blood.

Question Title

* 7. How long since you were first diagnosed with ITP?

Question Title

* 8. Have you ever received treatment for your ITP?

Question Title

* 9. Which of the following treatments are you currently receiving for your ITP?

Question Title

* 10. Which of the following treatments have you previously received for your ITP?

Question Title

* 11. Please select the treatments you have never received for your ITP.

Question Title

* 12. How long ago was your most recent course of [Nplate / Revolade ] treatment?

Question Title

* 13. Which of the following best describes where you live?

Question Title

* 14. As part of this research, you will be required to complete a diary task to enable us to understand more about your day-to-day life, and living with ITP. As part of these tasks, you will be asked to download an app, and the tasks may include submitting things such as video and audio recordings, photos and text. Consent to participate in these tasks will be obtained in a separate form.

Question Title

* 15. We would like to publish the data from this research in medical journals aimed at healthcare professionals, or at medical conferences attended by healthcare professionals. The purpose of publishing the results is to raise awareness amongst healthcare professionals of the challenges faced by people living with ITP. The findings would be fully anonymized, meaning that no participant would be identifiable.  
 
Do you consent to us using your data in an anonymized format for the purposes of publication as described above?

0 of 15 answered
 

T